Cointime

Synereca Pharmaceuticals

company

About

Synereca Pharmaceuticals develops orally-active drugs that restore the effectiveness of existing antibiotics.

  • 1 - 10

Highlights

Total Funding Amount
$2M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$600K
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2009
Number Of Employee
1 - 10
Operating Status
Active

Synereca Pharmaceuticals, Inc. develops orally active drugs that restore the effectiveness of existing antibiotics. Its portfolio includes prototypic RecA inhibitors, which target various pathogenic bacteria/E. coli, including those responsible for lung, urinary tract, and skin infections, as well as weaponizable gram-positive and gram-negative pathogens through various bactericidal antibiotics. The company was incorporated in 2009 and is based in Chapel Hill, North Carolina.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$2M
Synereca Pharmaceuticals has raised a total of $2M in funding over 2 rounds. Their latest funding was raised on Aug 4, 2015 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 4, 2015 Series Unknown $600K 1 Accele Venture Partners — Detail
Sep 16, 2014 Debt Financing $1.40M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Synereca Pharmaceuticals is funded by 1 investors. Accele Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Accele Venture Partners Yes Series Unknown
Cointime
เนื้อหา
บริษัท